The latest news & events
Keep up to date with company updates, industry news, investor
press releases and event information.
Kneat Announces New Director, New Omnibus Plan, and Release Date Q1 Results
LIMERICK, May 21, 2021 /CNW/ – kneat.com, inc. (TSXV: KSI) (“Kneat”) is pleased to announce the election of accomplished executive, Mrs. Nutan Behki, to its Board of Directors, the adoption of its new Omnibus Equity Incentive Plan, and the release date for the company’s first quarter financial
Read More
Kneat to Exhibit at 2021 ISPE USA Annual Meeting & Expo
2021 ISPE Annual Meeting & Expo USA The 2021 ISPE USA Annual Meeting & Expo, takes place on November 1st…
Read More
Kneat Sponsors PharmaTalk 2021
PharmaTalk 2021 PharmaTalk 2021, takes place on November 16th – 17th in Berlin, Germany PharmaTalk is a leading annual meeting…
Read More
Kneat Sponsors Manupharma 2021
Manupharma 2021 ManuPharma 2021, takes place on November 2nd – 3rd online (virtual event) Join Kneat as we support and…
Read More
Kneat to Feature at 2021 RQA International QA Conference
2021 RQA International QA Conference RQA International QA Conference 2021, takes place on November 3rd – 5th online (virtual event)…
Read More
Kneat Returns to IVT Validation Week, USA 2021
IVT Validation Week USA IVT Validation Week USA 2021, takes place on October 19th – 21st in San Diego, USA…
Read More
Kneat to Exhibit at ISPE Boston Product Show 2021
ISPE Boston Product Show 2021 ManuPharma 2019, takes place on September 15th in Boston, USA The Annual Product Show is…
Read More
Kneat to Co-Present with Customer at 2021 KenX Validation University Europe
2021 KenX Validation University Europe The 2021 KenX Validation University Europe conference, takes place virtually on June 28- 30, online….
Read More
Kneat Announces Selection by Top Ten Biopharma as the Corporate Solution for Global Manufacturing and Provides an Update on its Recent Financing
LIMERICK, May 7, 2021 /CNW/ – kneat.com, inc. (TSXV: KSI) (“Kneat”) announces it has signed a five-year corporate Master Services Agreement (MSA) with another top ten biopharma company, and provides an update on its recent financing. Top Ten Biopharma Selects Kneat as its Corporate Validation
Read More
Kneat Announces Closing of $20,125,575 Public Equity Financing and Concurrent $2,000,000 Non-Brokered Private Placement Equity Financing
HALIFAX, April 28, 2021 /CNW/ – kneat.com, inc. (TSXV: KSI) (“Kneat” or the “Company”) is pleased to announce that it has closed its previously announced short form prospectus offering, including the full exercise of the over-allotment option. As such, a total of 6,708,525 common shares of the
Read More
Kneat Announces New Nominee for Election to Board of Directors
LIMERICK, Ireland, April 22, 2021 /CNW/ – kneat.com, inc. (TSX-V: KSI) (“Kneat or the company”) is pleased to announce the nomination of accomplished executive, Mrs. Nutan Behki, to stand for election to the company’s board of directors at its 2021 annual general meeting, scheduled for May 20,
Read More
Kneat Announces $17.5 Million Bought Deal Public Offering
HALIFAX, Nova Scotia, April 7, 2021 – kneat.com, inc. (TSXV:KSI) (“Kneat” or the “Company”) is pleased to announce that it has entered into an agreement with a syndicate of investment dealers led by Cormark Securities Inc. (collectively, the “ Underwriters ”) pursuant to which the Underwriters
Read MoreContact
Talk to us
Find out how Kneat can make your validation easier, faster, and smarter.
Start your paperless validation revolution by speaking to our experts.